| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/19/1999 | CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | CA2319098A1 Cea/nca-based differentiation cancer therapy |
| 08/19/1999 | CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity |
| 08/19/1999 | CA2309705A1 Serological diagnosis of chagas' disease |
| 08/19/1999 | CA2286747A1 H2-o modified transgenic animals |
| 08/18/1999 | EP0936271A1 Calcium-activated potassium channel beta subunit gene and protein |
| 08/18/1999 | EP0935755A1 Use of abp as a prognostic and diagnostic indicator |
| 08/18/1999 | EP0935752A1 Methods for in vitro determination of erythropoietin bioactivity |
| 08/18/1999 | EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists |
| 08/18/1999 | EP0935662A2 Multiple epitope fusion protein |
| 08/18/1999 | EP0935661A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 08/18/1999 | EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 08/18/1999 | EP0935659A1 Compositions and methods for treating intracellular diseases |
| 08/18/1999 | EP0935658A1 Genetic control of flowering |
| 08/18/1999 | EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
| 08/18/1999 | EP0935656A1 Hedgehog interacting proteins and uses related thereto |
| 08/18/1999 | EP0935655A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 08/18/1999 | EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 08/18/1999 | EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 08/18/1999 | EP0935652A1 Keratinocyte growth factor-2 products |
| 08/18/1999 | EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY |
| 08/18/1999 | EP0935648A1 Improved adenovirus vectors |
| 08/18/1999 | EP0935612A1 Precursors of catalytic antibodies |
| 08/18/1999 | EP0935611A1 Serine protease inhibitors |
| 08/18/1999 | EP0935610A1 Novel human interferon-inducible protein |
| 08/18/1999 | EP0935609A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
| 08/18/1999 | EP0935608A1 Cytotoxic peptides |
| 08/18/1999 | EP0935607A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 08/18/1999 | EP0935605A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 08/18/1999 | EP0935604A1 Magnetically activated cell sorting for production of proteins |
| 08/18/1999 | EP0935603A2 Gene synthesis method |
| 08/18/1999 | EP0935470A1 Method for treating allergic lung disease |
| 08/18/1999 | EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 08/18/1999 | EP0792292B1 Orphan receptor |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0728217A4 Nucleic acid mutation detection by analysis of sputum |
| 08/18/1999 | EP0652895B1 Compounds which inhibit hiv replication |
| 08/18/1999 | EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/18/1999 | EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 08/18/1999 | CN1226285A Gene expression regulatory DNA, expression cassette and expression vector and transgenic plant |
| 08/18/1999 | CN1226284A Frozen food product containing heat stable antifreeze protein |
| 08/18/1999 | CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium |
| 08/18/1999 | CN1226176A Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 08/18/1999 | CN1226174A Use of proteinase inhibitors for prevention or reduction of bone resorption |
| 08/18/1999 | CN1226172A Method and compositions useful for inhibiting angiogenesis |
| 08/18/1999 | CN1226171A Type-2 chemokine binding proteins and methods of use thereof |
| 08/18/1999 | CN1226139A Frozen food with antifreezer peptides |
| 08/18/1999 | CN1226138A Frozen food with antifreezer peptides |
| 08/18/1999 | CN1225945A DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/18/1999 | CN1044709C Method for crystallizing itnerferon alpha-2 |
| 08/17/1999 | US5940560 Optical connection plug |
| 08/17/1999 | US5940198 Optical unit for synchronizing clock signals |
| 08/17/1999 | US5939603 Potyvirus resistance; chimeric plasmid; genetic engineering; dna sequences; gene expression |
| 08/17/1999 | US5939601 Genes associates with enhanced disease resistance in plants |
| 08/17/1999 | US5939600 Plants with reduced susceptibility; genetic engineering; transformation; diagnosis |
| 08/17/1999 | US5939599 High sulfur seed protein gene and method for increasing the sulfur amino acid contact of plants |
| 08/17/1999 | US5939598 Method of making transgenic mice lacking endogenous heavy chains |
| 08/17/1999 | US5939541 Supplying booster sequences encoding protein cleavage site required for autoproteolytic processing of genome of potyvirus; transgenic plants |
| 08/17/1999 | US5939540 Platelet secretory transport protein |
| 08/17/1999 | US5939536 Methods for purifying cystic fibrosis transmembrane conductance regulation |
| 08/17/1999 | US5939535 Compound modifies amino group of antigen; highly immunogenic and fluorescent; associated with alcohol liver disease |
| 08/17/1999 | US5939534 Factors mutated in the D1 cap region |
| 08/17/1999 | US5939529 Labeled container of modified or recombinant c-reactive protein; treatment of thrombocytopenia |
| 08/17/1999 | US5939528 Crystalline FRAP complex |
| 08/17/1999 | US5939526 Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof |
| 08/17/1999 | US5939525 Methods of treating inflammation and compositions therefor |
| 08/17/1999 | US5939524 Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use |
| 08/17/1999 | US5939400 DNA vaccination for induction of suppressive T cell response |
| 08/17/1999 | US5939393 Bactericidal factor in human airway surface fluid and uses thereof |
| 08/17/1999 | US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 08/17/1999 | US5939390 Pharmaceutical composition |
| 08/17/1999 | US5939388 Proteins for treatment of bone disorders |
| 08/17/1999 | US5939387 Insulin like growth hormone |
| 08/17/1999 | US5939386 Growth hormone (gh) or somatotropin, secreted by the pituitary gland constitute a family of hormones |
| 08/17/1999 | US5939385 Transglutaminase cross-linkable polypeptides and methods relating thereto |
| 08/17/1999 | US5939322 Human steroid receptor |
| 08/17/1999 | US5939321 Mammalian tolloid-like gene and protein |
| 08/17/1999 | US5939320 G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof |
| 08/17/1999 | US5939317 Use of a Sec-dependent secretion system for secreting proteins that are usually secreted by a Sec-independent secretion system, bacteria containing it and their use |
| 08/17/1999 | US5939316 Chromosome 18 marker |
| 08/17/1999 | US5939306 Osmosensing histidine kinases |
| 08/17/1999 | US5939304 Reacting active serine of thrombin with enzyme inhibitor; alkali treatment at ph not less than 11; recovering product in presence of polyhydric alcohols, saccharides, and salt or amphoteric electrolyte preventing coagulation |
| 08/17/1999 | US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds |
| 08/17/1999 | US5939297 Hybrid protein |
| 08/17/1999 | US5939289 DNA compounds comprising sequences encoding mannuronan C-5-epimerase |
| 08/17/1999 | US5939288 Efficient gene expression of endogenous or exogenous proteins into nectar by transforming plant cell with nucleic acid including signal sequence; for transgenic cells and plants |
| 08/17/1999 | US5939287 Method for production of proteins in yeast |
| 08/17/1999 | US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them |
| 08/17/1999 | US5939285 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site and vector therefor |
| 08/17/1999 | US5939284 Protein phosphatase 1 binding protein, R5 |
| 08/17/1999 | US5939283 Nucleotide sequences coding a protein that activates allergic responses |
| 08/17/1999 | US5939280 Immunological assay for quantifying peg-modified human granulocyte colony stimulating factor and monoclonal antibodies used in the assay |
| 08/17/1999 | US5939274 Immunological binding antibodies or fragments capable of specifically binding to peptide fragment derived from bone collagen |
| 08/17/1999 | US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens |
| 08/17/1999 | US5939270 Markers for organ rejection |
| 08/17/1999 | US5939264 Screening animals to determine those more likely to produce larger litters by assaying genetic material for the presence of polymorphism in a reproductive gene from the group including retinol binding protein 4, retenoic acid receptor |
| 08/17/1999 | US5939263 Neuropeptide Y receptor |
| 08/17/1999 | US5939262 Ribonuclease resistant RNA preparation and utilization |
| 08/17/1999 | US5939075 Mutants of Brucella melitensis |
| 08/17/1999 | US5939074 Polypeptides; useful for prodcution of vaccine against hiv infection and diagnosis |